{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:21:45Z","timestamp":1793326905009,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105416","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:10:59Z","timestamp":1780445459000},"page":"105416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gut microbiome dysbiosis and cancer: A systematic review on the emerging role of probiotics in oncology"],"prefix":"10.1016","volume":"225","author":[{"given":"Marjan","family":"Salehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3321-2218","authenticated-orcid":false,"given":"Andrea","family":"Gottardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tancredi Didier","family":"Bazan Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bonventre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Gristina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Trecciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Galvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6103","key":"10.1016\/j.critrevonc.2026.105416_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105416_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1208044","article-title":"The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice","volume":"14","author":"Asseri","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105416_bib3","article-title":"Oncogenic","volume":"13","author":"Bansod","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105416_bib4","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105416_bib5","first-page":"326","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105416_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(13)70107-5","article-title":"The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease","volume":"13","author":"Boleij","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105416_bib7","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105416_bib8","unstructured":"Chandra, P., H. Sharma, and N. Sachan, (n.d) The Potential Role of Prebiotics, Probiotics, and Synbiotics in Cancer Prevention and Therapy., in Synbiotics in Metabolic Disorders. CRC Press."},{"issue":"52","key":"10.1016\/j.critrevonc.2026.105416_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203894119","article-title":"Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105416_bib10","article-title":"Editorial: deciphering the microbiome-immunity-cancer axis","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smim.2017.08.001","article-title":"Microbiota dysbiosis in select human cancers: evidence of association and causality","volume":"32","author":"Chen","year":"2017","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105416_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12275-024-00110-7","article-title":"The microbiome matters: its impact on cancer development and therapeutic responses","volume":"62","author":"Chung","year":"2024","journal-title":"J. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fphys.2016.00606","article-title":"Host-microbiome interaction and cancer: potential application in precision medicine","volume":"7","author":"Contreras","year":"2016","journal-title":"Front. Physiol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105416_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","article-title":"Targeting the gut microbiota for cancer therapy","volume":"22","author":"Fernandes","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105416_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105416_bib16","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1210\/jc.2014-2222","article-title":"Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women","volume":"99","author":"Fuhrman","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105416_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv147","article-title":"Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study","volume":"107","author":"Goedert","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105416_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/carcin\/23.3.529","article-title":"Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA","volume":"23","author":"Huycke","year":"2002","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105416_bib19","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/2159-8290.CD-21-0324","article-title":"The cancer microbiome: recent highlights and knowledge gaps","volume":"11","author":"Knippel","year":"2021","journal-title":"Cancer Discov."},{"issue":"27","key":"10.1016\/j.critrevonc.2026.105416_bib20","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3748\/wjg.v28.i27.3370","article-title":"Probiotics and postbiotics in colorectal cancer: prevention and complementary therapy","volume":"28","author":"Kvakova","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105416_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12200","article-title":"Harness the functions of gut microbiome in tumorigenesis for cancer treatment","volume":"41","author":"Lee","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.critrevonc.2026.105416_bib22","article-title":"Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105416_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4251\/wjgo.v15.i5.757","article-title":"Immuno-oncology-microbiome axis of gastrointestinal malignancy","volume":"15","author":"Lin","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1438657","article-title":"The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group","volume":"14","author":"Mego","year":"2024","journal-title":"Front. Oncol."},{"issue":"9-10","key":"10.1016\/j.critrevonc.2026.105416_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/jimb\/kuab052","article-title":"Challenges in the production and use of probiotics as therapeuticals in cancer treatment or prevention","volume":"48","author":"Mej\u00eda-Caballero","year":"2021","journal-title":"J. Ind. Microbiol. Biotechnol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105416_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603990","article-title":"Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study","volume":"97","author":"Osterlund","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105416_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12032-025-02708-2","article-title":"Therapeutic potential of microbiome modulation in reproductive cancers","volume":"42","author":"Oyovwi","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jss.2025.05.026","article-title":"Do perioperative probiotics\/synbiotics reduce postoperative infection rates following elective colorectal surgery? A systematic review and meta-analysis","volume":"312","author":"Paterson","year":"2025","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.critrevonc.2026.105416_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.878297","article-title":"Effects of probiotics at the interface of metabolism and immunity to prevent colorectal cancer-associated gut inflammation: a systematic network and meta-analysis with molecular docking studies","volume":"13","author":"Patra","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112898","article-title":"Microbiome in cancer: role in carcinogenesis and impact in therapeutic strategies","volume":"149","author":"Rahman","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"33","key":"10.1016\/j.critrevonc.2026.105416_bib31","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3748\/wjg.v26.i33.4919","article-title":"Exploring the food-gut axis in immunotherapy response of cancer patients","volume":"26","author":"Russo","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105416_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/1871520621999201210220442","article-title":"Potential impacts of prebiotics and probiotics on cancer prevention","volume":"22","author":"Samanta","year":"2022","journal-title":"Anticancer. Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105416_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11912-014-0406-0","article-title":"Cancer-promoting effects of microbial dysbiosis","volume":"16","author":"Sheflin","year":"2014","journal-title":"Curr. Oncol. Rep."},{"issue":"Pt B","key":"10.1016\/j.critrevonc.2026.105416_bib34","article-title":"Gut Lactobacillus contribute to the progression of breast cancer by affecting the anti-tumor activities of immune cells in the TME of tumor-bearing mice","volume":"124","author":"Shi","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2025.103151","article-title":"Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: a systematic review and meta-analysis","volume":"89","author":"Siritientong","year":"2025","journal-title":"Complement. Ther. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105416_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010020","article-title":"The role of probiotics in cancer prevention","volume":"13","author":"\u015ali\u017cewska","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105416_bib37","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.21037\/tlcr-23-231","article-title":"A comparison of the microbiome composition in lower respiratory tract at different sites in early lung cancer patients","volume":"12","author":"Su","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105416_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4103\/ijmr.IJMR_1026_18","article-title":"Role of microbial dysbiosis in carcinogenesis & cancer therapies","volume":"152","author":"Vimal","year":"2020","journal-title":"Indian. J. Med. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105416_bib39","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1462-5822.2008.01122.x","article-title":"Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment","volume":"10","author":"Weibel","year":"2008","journal-title":"Cell. Microbiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105416_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","article-title":"Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer","volume":"25","author":"Wirbel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105416_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1051330","article-title":"Role of microbes in colorectal cancer therapy: cross-talk between the microbiome and tumor microenvironment","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105416_bib42","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1245\/s10434-024-15394-7","article-title":"Probiotic compounds enhanced recovery after surgery for patients with distal gastric cancer: a prospective, controlled clinical trial","volume":"31","author":"Xiong","year":"2024","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105416_bib43","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.18632\/oncotarget.7045","article-title":"The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105416_bib44","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/s41467-021-27112-y","article-title":"Dysbiosis of human gut microbiome in young-onset colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105416_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277155","article-title":"Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition","volume":"18","author":"Yang","year":"2023","journal-title":"PLoS. One"},{"key":"10.1016\/j.critrevonc.2026.105416_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1126808","article-title":"Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105416_bib47","article-title":"The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:39:55Z","timestamp":1787107195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S1040842826003033"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105416","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome dysbiosis and cancer: A systematic review on the emerging role of probiotics in oncology","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105416"}}